LexaGene Holdings Inc. (LXXGF)
| Previous Close | 0.1756 |
| Open | 0.1828 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1700 - 0.1828 |
| 52 Week Range | 0.0500 - 0.3860 |
| Volume | |
| Avg. Volume | 180,248 |
| Market Cap | 20.822M |
| Beta (5Y Monthly) | 1.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0950 |
| Earnings Date | Jun 28, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
LexaGene Successfully Completes Statement of Work for BioPharma Company
BEVERLY, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing, is pleased to announce the completion of a validation study with a major biopharma company that recently purchased a MiQLab System for the possible use of the technology in its manufacturing processes. Dr. Jack Regan, LexaGene’s CEO and Founder co
- GlobeNewswire
LexaGene Closes Secured Convertible Note Transaction
BEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated multiplex PCR testing, announces that it has issued a 12% secured convertible note (the “Note”) to Meridian LGH Holdings 2, LLC, an affiliate of an insider of the Company, in the aggregate principal amount of up to USD$1,600,000. The Note matures on March 1, 2023. The Note is s
- GlobeNewswire
LexaGene Holdings Proposes to Amend Warrants Terms
BEVERLY, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated multiplex PCR testing, announces that it intends to amend the exercise price of certain common share purchase warrants (the “Warrants”) originally issued on October 29, 2019. An aggregate of 12,769,626 Warrants were initially issued with an exercise price of CAD$0.75 per common
